Research on GLP-1s in Addiction Treatment

SUD Care Continuum ECHO®: Research on GLP-1s in Addiction Treatment

As part of the twice-monthly SUD Care Continuum ECHO® series, Joji Suzuki, MD, will describe the GLP-1 drug class and discuss the emerging evidence base for its role in addiction treatment. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.

Following this training, participants will have the knowledge to:

• Describe the GLP-1 drug class.
• Discuss the emerging evidence base for the role of GLP-1s in addiction treatment.

Learn more & register

For trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements.